Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study von Bain, Stephen C, Carstensen, Bendix, Hyveled, Liselotte, Seremetis, Stephanie, Flindt Kreiner, Frederik, Amadid, Hanan, Clark, Alice

Volltext

The role of weight control in the management of type 2 diabetes mellitus: Perspectives on semaglutide von Kurtzhals, Peter, Flindt Kreiner, Frederik, Singh Bindra, Rubdeep

Volltext

Molecular engineering of insulin for recombinant expression in yeast von Kjeldsen, Thomas, Andersen, Asser Sloth, Hubálek, František, Johansson, Eva, Kreiner, Frederik Flindt, Schluckebier, Gerd, Kurtzhals, Peter

Volltext

Glucagon‐like peptide‐1 receptor agonists to expand the healthy lifespan: Current and future potentials von Kreiner, Frederik Flindt, von Scholten, Bernt Johan, Kurtzhals, Peter, Gough, Stephen Charles Langford

Volltext

Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: Effects on weight loss and safety in adults with overweight or obesity von Friedrichsen, Martin Haljeta, Endahl, Lars, Kreiner, Frederik Flindt, Goldwater, Ronald, Kankam, Martin, Toubro, Søren, Nygård, Sune Boris

Volltext

The potential of glucagon-like peptide-1 receptor agonists in heart failure von Kreiner, Frederik Flindt, Hovingh, G. Kees Kornelis, von Scholten, Bernt Johan

Volltext

Corrigendum to “Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: effects on weight loss and safety in adults with overweight or obesity” [Mo... von Friedrichsen, Martin Haljeta, Endahl, Lars, Kreiner, Frederik Flindt, Goldwater, Ronald, Kankam, Martin, Toubro, Søren, Nygård, Sune Boris

Volltext

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice von von Scholten, Bernt Johan, Kreiner, Frederik Flindt, Rasmussen, Søren, Rossing, Peter, Idorn, Thomas

Volltext

Surrogate endpoint evaluation using data from one large global randomized controlled trial von Geybels, Milan, Wolthers, Benjamin Ole, Kreiner, Frederik Flindt, Rasmussen, Søren, Bauer, Robert

Volltext

Gene expression profiling in patients with polymyalgia rheumatica before and after symptom-abolishing glucocorticoid treatment von Kreiner, Frederik Flindt, Borup, Rehannah, Nielsen, Finn Cilius, Schjerling, Peter, Galbo, Henrik

Volltext

Corrigendum to "Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: effects on weight loss and safety in adults with overweight or obesity" Mol... von Friedrichsen, Martin Haljeta, Endahl, Lars, Kreiner, Frederik Flindt, Goldwater, Ronald, Kankam, Martin, Toubro, Søren, Nygård, Sune Boris

Volltext

Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-[alpha] blocking etanercept treatment von Kreiner, Frederik Flindt, Galbo, Henrik

Volltext

Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-α blocking etanercept treatment von Kreiner, Frederik Flindt, Galbo, Henrik

Volltext

Insulin at 100: still central in protein-based therapy for chronic disease von Kurtzhals, Peter, von Scholten, Bernt Johan, Kreiner, Frederik Flindt, Gough, Stephen Charles Langford

Volltext